Budapest – Ceva’s Hungarian Headquarters​

Thanks to Phylaxia's activities, our presence in Hungary dates back more than 110 years. We remain proud of our heritage, as it drives our constant development.​

We currently employ more than 1,400 people, and our team is steadily expanding. ​

Our Budapest site is a cornerstone of the Ceva Group, both locally and globally. In addition to producing 50 different vaccines to prevent 25 diseases, it hosts the group's largest biological R&D center and our SSIU Directorate.

​

Monor – The Future of Our Expansion​

Since 2021, we have been operating across two locations. Our 50-hectare greenfield Linilog logistics center in Monor is unique in Europe. It houses the continent’s largest cryogenic vaccine storage system, where products are stored at –196°C in liquid nitrogen. 

The Monor site will accommodate additional operations in the future. A new manufacturing facility is currently under development and will begin operations in 2027, creating 120 new high-skilled jobs.​